The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment

Aims: Recent findings suggest that cognitive impairment can be associated with inflammation and immune changes in schizophrenia. We aimed to study possible associations between cytokine levels and cognitive performance in a sample of patients with schizophrenia. Methods: Cognition was assessed with the brief assessment of cognition in schizophrenia in 63 clinically stable outpatients with schizophrenia. Blood was collected and cytokines (IL-2, IL-4, IL-6, IL-10, IL-17A, TNF-α, IFN-γ) were measured by cytometric bead array method. Psychopathological scales were also applied. Results: IL-6 correlated negatively with general cognitive performance (rho = –0.395, p =.017) and positively with antipsychotic dose (rho = 0.412, p =.004). Multiple regression analysis showed that cognitive performance is associated with age and antipsychotic dose (p =.000 and p =.033). Conclusion: The association between IL-6 levels and cognitive performance is dependent on age and antipsychotic dose.